Plasma methylmalonic acid predicts risk of acute myocardial infarction and mortality in patients with coronary heart disease: A prospective 2-cohort study.
Indu DharVegard LysneArve UlvikGard F T SvingenEva R PedersenEspen Ø BjørnestadThomas OlsenRobert BorsholmJohnny Laupsa-BorgePer M UelandGrethe S TellRolf K BergeGunnar MellgrenKaare H BønaaOttar K NygårdPublished in: Journal of internal medicine (2023)
Elevated MMA was associated with an increased risk of AMI and mortality in patients with suspected or verified CHD.